FUND MATERIAL
Download additional information on ARKK.
 Fact Sheet |
| Prospectus |
| Prospectus Supplement |
| Summary Prospectus |
| Fund Holdings PDF |
 Fund Holdings CSV |
| Quarterly Report |
| Semi-Annual Report |
| Annual Report |
| SAI |
 XBRL |
| Month-End Performance |
| Active Share Sheet |
FUND DESCRIPTION
Securities within ARKK represent ARK’s cornerstone investment ideas from the three thematic strategies applied in ARKG, ARKQ, ARKW that ARK believes present the best risk-reward opportunities. Companies in ARKK include those that rely on or benefit from the development of new products or services, technological improvements and advancements in scientific research relating to the following areas:
For full description of the listed strategies click here.
| Ticker: | ARKK |
| Primary Exchange: | NYSE Arca |
| CUSIP: | 00214Q 104 |
| Fund Type: | Active Equity ETF |
| Inception Date: | 10/31/2014 |
| Portfolio Managers: | Catherine D. Wood |
| Indicative Value: | ARKK.IV |
| Net Asset Value (NAV): | ARKK.NV |
| Typical # of Holdings: | 40-55 Domestic Equities & US-listed ADRs |
| Expense Ratio: | 0.75% |
| Weighted Avg. Market CAP: | $84 Billion |
| Median Market CAP: | $7 Billion |
ARKK PERFORMANCE*
As of 12/31/2017
| ARKK | 3 Months | YTD | 1 Year | Since Inception(annualized) |
| NAV | 9.84% | 87.41% | 87.41% | 22.82% |
| Market Price | 9.56% | 87.37% | 87.37% | 22.88% |
*Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The
investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. Returns for less than one year are not annualized. Net asset value (“NAV”) returns are based on the dollar value of a single share of the ETF, calculated using the value of the underlying assets of the ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of the ETF’s shares may differ significantly from their NAV during periods of market volatility.
NAV AND MARKET PRICE
FUND COMPOSITION AND OBJECTIVE
ARKK is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 65% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies that are relevant to the Fund’s investment theme of disruptive innovation.
ARKK ACTIVE SHARE
As of 12/31/2017
| S&P 500 INDEX | MSCI WORLD INDEX | |
| ARK INNOVATION ETF | 92% | 95% |
Active Share is the proportion of stock holdings in a fund’s portfolio that is different from the composition found in the benchmark.
The Premium/Discount chart shows the difference between the daily market price of the Fund’s shares and the Fund’s net asset value (“NAV”). The daily market price is calculated using the mid-point between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund’s NAV is calculated (usually 4:00 pm Eastern time). The vertical axis of the chart shows the premium or discount of the Mid-Point price as a percentage of the NAV. The horizontal axis shows the number of trading days covered by the chart, and each bar in the chart demonstrates how many days the Fund traded within the given premium/discount range. The data presented in the chart and table above represent past performance and cannot be used to predict future results.
ARK offers fully transparent ETFs and discloses intra-day trades for the ARKK ETF. Files of intra-day trades are not provided until full trade execution (with reasonable time to post). Click here to see intra-day trades of the current day.
DISCLOSURES
The principal risks of investing in ARK’s actively managed ARKK ETF include equity, market, management, concentration and non-diversification risks, as well as fluctuations in market value and net asset value (“NAV”). The principal risks of investing in ARKK: Equity Securities Risk. The value of the equity securities the Fund holds may fall due to general market and economic conditions. Foreign Securities Risk. Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities. Health Care Sector Risk. The health care sector may be adversely affected by government regulations and government health care programs. Industrials Sector Risk. Companies in the industrials sector may be adversely affected by changes in government regulation, world events, economic conditions, environmental damages, product liability claims and exchange rates. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins.
Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security.
[1] Source: ARK Investment Management LLC, Research
ARKK Full Description:
Genomic Revolution: Companies that are substantially focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business, such as by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation. These companies may be from multiple sectors (such as health care, information technology, materials, energy or consumer discretionary) and may include companies that develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine, and agricultural biotechnology.
Industrial Innovation: Companies that are expected to focus on and benefit from the development of new products or services, technological improvements and advancements in scientific research related to, among other things, disruptive innovation in energy (i.e. storage, collection or implementation of new sources, production or development of new materials), automation and manufacturing (i.e. productivity of machines, automation of functions, processes or other activities, or the use of robotics to perform other functions, activities or processes), materials, and transportation.
Web x.0: Companies that are focused on and expected to benefit from shifting the bases of technology infrastructure from hardware and software to the cloud, enabling mobile and local services, such as companies that rely on or benefit from the increased use of shared technology, infrastructure and services. These companies may also include ones that develop, use or rely on innovative payment methodologies, big data, the internet of things, and social distribution and media.
